You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Third-generation cephalosporin-resistant Enterobacteriaceae.

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Empirical Antibiotic and Outcome in Community-onset Bacteremia

Recruiting
  • Bacteremia
    • Bangkok, Thailand
      Worapong Nasomsong
    Sep 16, 2020

    Beta Lactam Resistant Bacterial Infection, Enterobacteriaceae Infections, Bacteremia Trial in Canada, Israel

    Recruiting
    • Beta Lactam Resistant Bacterial Infection
    • +2 more
    • Montreal, Quebec, Canada
    • +7 more
    Jul 25, 2022

    Temocillin in ESBL-Enterobacteriaceae Infections

    Not yet recruiting
    • Infectious Disease
    • Temocillin
    • (no location specified)
    Jun 7, 2022

    Patients Receiving Ceftriaxone in Hospital Emergency Unit Trial in Nantes (Rectal swab collection)

    Terminated
    • Patients Receiving Ceftriaxone in Hospital Emergency Unit
    • Rectal swab collection
    • Nantes, France
      Nantes university Hospital
    Sep 26, 2022

    Carbapenem-Resistant Enterobacteriaceae Infection Trial in China (treatment with or without colistin)

    Not yet recruiting
    • Carbapenem-Resistant Enterobacteriaceae Infection
    • treatment with or without colistin
    • Hefei, Anhui, China
    • +13 more
    Sep 20, 2023

    Bacteremia Trial in Spain (Temocillin, Meropenem)

    Recruiting
    • Bacteremia
    • Santiago de Compostela, A Coruña, Spain
    • +31 more
    Oct 14, 2021

    Lung Cancer, Non-small Cell, EGFR Gene Mutation, EGFR-TKI Resistant Mutation Trial in Changsha (Genomic profiles detection,

    Recruiting
    • Lung Cancer, Non-small Cell
    • +4 more
    • Genomic profiles detection
    • circulating tumor DNA detection
    • Changsha, Hunan, China
      Department of Oncology, The Second Xiangya Hospital, Central Sou
    Oct 25, 2022

    Bacteremia Due to Methicillin Susceptible Staphylococcus Aureus Trial in Paris (Cloxacillin, Cefazolin)

    Recruiting
    • Bacteremia Due to Methicillin Susceptible Staphylococcus Aureus
    • Paris, France
      François-Xavier Lescure
    Dec 7, 2022

    Prophylactic Antibiotics in Compensated Liver Cirrhosis

    Not yet recruiting
    • Liver Cirrhosis
    • Upper Gastrointestinal Bleeding
    • Third generation cephalosporin antibiotics
    • (no location specified)
    Jan 12, 2021

    Infections and Colonization With Third Group of

    Completed
    • Critically Ill
    • +2 more
      • Vandoeuvre Les Nancy, Lorraine, France
        Emmanuel NOVY
      Aug 24, 2020

      Beta Lactam Resistant Bacterial Infection, Enterobacteriaceae Infections, Bacteremia Trial in Israel (Piperacillin / Tazobactam

      Recruiting
      • Beta Lactam Resistant Bacterial Infection
      • +2 more
      • Haifa, Israel
      • +3 more
      Jul 25, 2022

      Surgical Site Infection, Antibiotics Prophylaxis Trial in Ibadan (Cefuroxime (Zinnat®), Ceftriaxone (Rocephin®))

      Recruiting
      • Surgical Site Infection
      • Antibiotics Prophylaxis
      • Cefuroxime (Zinnat®)
      • Ceftriaxone (Rocephin®)
      • Ibadan, Oyo, Nigeria
        University College Hospital
      May 27, 2022

      Estrogen Receptor Positive Breast Cancer Trial in United Kingdom (AZD5363, Placebo, Fulvestrant)

      Active, not recruiting
      • Estrogen Receptor Positive Breast Cancer
      • Manchester, Greater Manchester, United Kingdom
      • +20 more
      Aug 5, 2022

      Carbapenem-Resistant Enterobacteriaceae, Vancomycin (Glycopeptide) Resistant Enterococcus (VRE) Trial in Chuncheon, Seoul (fecal

      Not yet recruiting
      • Carbapenem-Resistant Enterobacteriaceae
      • Vancomycin (Glycopeptide) Resistant Enterococcus (VRE)
      • fecal microbiota transplantation
      • Chuncheon, Gangwon-do, Korea, Republic of
      • +1 more
      Aug 18, 2023

      Bacteremia Caused by Gram-Negative Bacteria Trial in Worldwide (Ceftolozane-Tazobactam, Meropenem)

      Withdrawn
      • Bacteremia Caused by Gram-Negative Bacteria
      • Newcastle, New South Wales, Australia
      • +28 more
      May 17, 2022

      Infectious Disease - Resistant Enterobacteriaceae (Diagnosis) Trial in Besançon (Cefotaxime Injection, Rectal swab,

      Unknown status
      • Infectious Disease - Resistant Enterobacteriaceae (Diagnosis)
      • Cefotaxime Injection
      • +2 more
      • Besançon, France
        CHU de Besançon
      Apr 18, 2019

      Surgical Site Infection Trial in Dammam (Cefuroxime, Cefazolin, 24 hours)

      Completed
      • Surgical Site Infection
      • Dammam, Eastern Province, Saudi Arabia
        Saud AlBabtain Cardiac Center
      Oct 6, 2022

      Colistin-resistant Isolates From Patients of Intensive Care

      Completed
      • Colistin Resistance in Bacteria
      • Rapid Polymyxin NP test
      • Bordeaux, France
      • +3 more
      Mar 11, 2022

      Multidrug Resistant Bacterial Infection, Enterobacteriaceae Infections, Pseudomonas Aeruginosa Trial in Philadelphia (PMT)

      Not yet recruiting
      • Multidrug Resistant Bacterial Infection
      • +4 more
      • Philadelphia, Pennsylvania
        Hospital of the University of Pennsylvania
      Nov 17, 2022

      Nasal Obstruction, Nasal Surgical Procedures Trial in Stanford (Intra-operative single intravenous(iv) dose of "cephalexin" 2 g

      Enrolling by invitation
      • Nasal Obstruction
      • Nasal Surgical Procedures
      • Intra-operative single intravenous(iv) dose of "cephalexin" 2 g or "clindamycin" 900 mg.
      • Intra-operative single dose (iv) of "cephalexin" 2 g or "clindamycin" 900 mg and postoperative oral dose of "cephalexin" 250mg (every 4 hours) or "clindamycin" 150mg(every 6 hours) for 3 days
      • Stanford, California
        Facial Plastic and Reconstructive Surgery Clinic
      Oct 26, 2022

      Community-acquired Pneumonia (CAP), Hospital-acquired Pneumonia (HAP) Trial in Worldwide (ceftobiprole medocaril, IV

      Completed
      Has Results
      • Community-acquired Pneumonia (CAP)
      • Hospital-acquired Pneumonia (HAP)
      • ceftobiprole medocaril
      • IV standard-of-care cephalosporin
      • Pleven, Bulgaria
      • +18 more
      Mar 7, 2022

      Liver Transplant Recipients Colonized With Carbapenem Resistant

      Not yet recruiting
      • Liver Transplantation
      • Carbapenem-Resistant Enterobacteriaceae Colonization
      • Application of a prognostic score
      • São Paulo, Brazil
      • +5 more
      Oct 21, 2022

      Anti-bacterial Agents, Pharmacokinetics, General Surgery Trial in Seoul (target-controlled infusion (one of the administration

      Recruiting
      • Anti-bacterial Agents
      • +2 more
      • target-controlled infusion (one of the administration methods)
      • Standard administration method
      • Seoul, Songpa-Gu,, Korea, Republic of
        Asan Medical Center
      Apr 11, 2022

      Pyelonephritis Acute Trial in France (IV Antibacterial Agents, Orally antibacterial agents, Fecal/Rectal Swab)

      Not yet recruiting
      • Pyelonephritis Acute
      • IV Antibacterial Agents
      • +4 more
      • Longjumeau, Essonne, France
      • +18 more
      Sep 14, 2022

      Urinary Tract Infections Trial in Nantes (Dissemination of a selective reporting for antibiotic susceptibility testing, Standard

      Not yet recruiting
      • Urinary Tract Infections
      • Dissemination of a selective reporting for antibiotic susceptibility testing
      • Standard antibiotic susceptibility testing report
      • Nantes, France
        University Hospital
      Sep 28, 2023